SLC2A4 and type 2 diabetes mellitus: Some researches have shown [17] that the inhibition of the expression of the LKB1–AMPK–GLUT4 signaling cascade in the skeletal muscle of patients with type 2 diabetes reduced the transfer efficiency of glycogen in the skeletal muscle, thus decreasing the insulin sensitivity and glucose disposal rate in the blood and increasing the blood glucose level.